In 2023, and as of 23 August, over 3.7 million cases and over 2 000 dengue-related deaths have been reported from 70 countries/territories globally. In July-August 2023, six autochthonous/non-travel associated dengue cases have been reported in Europe.
Since last week’s update, and as of 23 August 2023, European Union (EU) and European Economic Area (EEA) countries reported 104 human cases of West Nile virus (WNV) infection and 8 deaths related to WNV infections.
Since the beginning of the 2023 transmission season and as of 23 August 2023, EU/EEA countries have reported 229 human cases of WNV infection and 13 outbreaks among equids and 60 outbreaks among birds.
Since last week’s update, and as of 23 August 2023, European Union (EU) and European Economic Area (EEA) countries reported 104 human cases of West Nile virus (WNV) infection and 8 deaths related to WNV infections.
Prevalence data from sources such as population surveys can be a useful complement to case based surveillance data for hepatitis B. Case-based surveillance has limitations as most diagnosed cases are chronic in nature and detection of cases depends largely on testing practices. Prevalence data can therefore contribute towards a fuller understanding of the epidemiology of hepatitis B.
Anthrax continues to be uncommon in humans in the EU/EEA, with only a few cases reported every year. For 2021, four confirmed anthrax cases were reported by Bulgaria (one case) and Spain (three cases). Among 30 reporting EU/EEA countries, 27 notified zero cases.
This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised mitigation measures for preventing transmission through SoHO.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 August and includes updates on avian influenza A(H5N6), avian influenza A(H9N2), West Nile virus, COVID-19, poliomyelitis, and Crimean-Congo haemorrhagic fever.